247 related articles for article (PubMed ID: 6241506)
1. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of six beta-lactams and six quinolones against urinary gram negative bacteria.
Galante D; Esposito S; Barba D
Boll Ist Sieroter Milan; 1986; 65(5):361-7. PubMed ID: 3828090
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Galante D; Pennucci C; Esposito S; Barba D
Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
Esposito S; Galante D; Pennucci C; Barba D
Microbiologica; 1985 Jul; 8(3):269-76. PubMed ID: 3162081
[TBL] [Abstract][Full Text] [Related]
5. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
6. Cross resistance of quinolone derivatives in gram-negative bacteria.
Barba D; Pennucci C; Esposito S; Galante D
Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
[TBL] [Abstract][Full Text] [Related]
7. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
9. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
[TBL] [Abstract][Full Text] [Related]
12. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
Fromtling RA; Abruzzo GK; Gadebusch HH
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M
Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429
[TBL] [Abstract][Full Text] [Related]
14. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
15. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
Piccolomini R; Ravagnan G
Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases.
Esposito S; Galante D; Barba D; Pennucci C; Limauro D
Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
Esko E; Renkonen OV
Scand J Infect Dis; 1985; 17(1):95-8. PubMed ID: 3158071
[TBL] [Abstract][Full Text] [Related]
18. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
Cahen P; Honderlick P
Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Bauernfeind A; Petermüller C
Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Shah PM; Ottnad-Walz M; Stille W
Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
